Latest Options News

Theta Gold Mines has completed a significant capital raising, securing nearly A$20 million through a placement and the first tranche of a cornerstone investment, setting the stage for advancing its TGME Gold Project.

Johns Lyng Group’s acquisition by Sherwood BidCo has been legally approved, triggering a suspension of JLG shares on the ASX. Shareholders are set to receive $4 per share or scrip consideration by late October.

Wildcat Resources has dismissed reports of selling half its Tabba Tabba Project, confirming instead that it is exploring multiple funding avenues to advance the project.

Western Mines Group has raised $3.71 million through a share placement to fund expanded exploration at its Mulga Tank nickel project, signaling renewed investor confidence in the nickel sector.

Elevate Uranium Ltd has agreed to sell its Oobagooma Uranium Project to Orpheus Uranium Ltd in a deal combining cash and milestone-based equity payments, aligning with Elevate’s pivot towards its innovative U-pgrade beneficiation technology and other core assets.

Capstone Copper has struck a strategic deal with Orion Resource Partners, unlocking up to $360 million for a 25% stake in its Santo Domingo and Sierra Norte projects, accelerating development in Chile’s Atacama region.

Catalina Resources has received all assay results from its September 2025 drilling at the Halo Gold Project, confirming extended gold mineralisation along strike and at depth, including standout high-grade intersections.

Zeotech Limited has signed a non-binding MOU with Cement Australia to collaborate on advancing AusPozz™, a high-reactivity metakaolin product aimed at reducing carbon emissions in concrete production.

Altech Batteries has raised $6 million through a share placement to accelerate development and commercialisation of its innovative battery technologies, including the CERENERGY solid-state battery and Silumina Anodes.

Titanium Sands Limited has locked in $800,000 in stage two funding to complete environmental studies and advance the Industrial Mining Licence for its Mannar Island Project in Sri Lanka, backed by strong government support.

Tryptamine Therapeutics has enrolled the first patient in its pioneering clinical trial testing TRP-8803, an IV-infused psilocin formulation, for Binge Eating Disorder. The study aims to evaluate safety and efficacy, potentially reshaping treatment options for millions.

Gryphon Capital Income Trust (ASX, GCI) has opened a non-underwritten unit purchase plan offering new units at A$2.00 each to eligible unitholders in Australia and New Zealand. The offer aims to raise up to A$337 million to support portfolio growth.